查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2016402

人类绒毛膜促性腺激素分泌市场报告：按技术、治疗领域、最终用户和地区划分（2026-2034 年）

Human Chorionic Gonadotropin Market Report by Technology, Therapeutic Area, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

2025年，全球人类绒毛膜促性腺激素分泌（HCG）市场规模达11.038亿美元。展望未来，IMARC集团预测，到2034年，市场规模将达到19.059亿美元，2026年至2034年的复合年增长率（CAGR）为6.07%。女性不孕症发生率上升、性腺功能减退相关疾病盛行率增加、采用重组技术生产HCG是推动市场成长的主要因素。

人类绒毛膜促性腺激素分泌(HCG) 是怀孕期间由胎盘合体滋养层细胞产生的化学物质。它存在于血液、尿液、肝臟、结肠和脑下垂体。 HCG 刺激层析法、染料亲和性和层析法、奈米过滤和反相高效液相层析(HPLC)。 HCG 广泛用于治疗不孕症、提高受孕几率、促进睪固酮和精子生成以及治疗男婴隐睪。它还可用于诊断和后续观察妊娠相关疾病、产前筛检以及妇科癌症的诊断。

人类绒毛膜促性腺激素分泌（HCG）市场趋势：

子宫疾病、输卵管阻塞、卵巢症候群（PCOS）和内分泌失调导致女性不孕症的发生率不断上升，是推动市场成长的主要因素之一。 HCG广泛应用于各种辅助生殖技术，例如体外受精（IVF）和子宫内人工授精（IUI），用于治疗女性不孕症，因为它有助于诱导排卵、促进胚胎发育、确保最佳卵子时机、增加子宫内膜厚度并提高子宫内膜容受性。此外，该产品与其他不孕症治疗方法合併使用，以提高女性的怀孕几率，也是推动市场成长的另一个因素。此外，肥胖和第2型糖尿病男性中性腺功能减退相关疾病的盛行率不断上升，导致HCG的使用量增加，以提高睪固酮水平、增强生育能力和改善性功能，这也促进了市场成长。此外，以重组技术生产的HCG与天然HCG具有相同的特性，且疗效更佳、安全性更高，并能提高患者的耐受性，这正积极推动市场成长。其他预计将进一步促进市场成长的因素包括：医疗基础设施的快速发展、生育治疗及相关服务的普及、老年人口的增长、旨在引入新型纯化和提取技术的广泛研发活动，以及政府为改善民众性健康而采取的各项措施。

本报告解答的主要问题

  • 迄今为止，全球人类绒毛膜促性腺激素分泌(HCG) 市场的发展趋势是什么？您预计未来几年这些趋势将如何发展？
  • 全球人类绒毛膜促性腺激素分泌(HCG) 市场的市场驱动因素、阻碍因素和机会是什么？
  • 主要区域市场有哪些？
  • 在人类绒毛膜促性腺激素分泌（HCG）市场中，哪个国家最具吸引力？
  • 市场按技术划分是怎样的？
  • 按治疗区域分類的市场组成是什么？
  • 依最终用户分類的市场区隔如何？
  • 全球人类绒毛膜促性腺激素分泌（HCG）市场的竞争格局如何？
  • 全球人类绒毛膜促性腺激素分泌(HCG) 市场的主要参与者/公司有哪些？

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球人类绒毛膜促性腺激素分泌市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依技术划分

  • 从自然资源中提取资源
  • 重组技术

第七章 市场区隔：依治疗领域划分

  • 女性不孕症治疗
  • 男性性腺功能低下症
  • 少精症治疗
  • 其他的

第八章 市场区隔：依最终用户划分

  • 不孕症治疗诊所
  • 研究机构
  • 其他的

第九章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章：促进、抑制与机会

第十一章：价值链分析

第十二章：波特五力分析

第十三章：价格分析

第十四章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Biocare Medical LLC
    • Ferring Pharmaceuticals
    • Fresenius SE & Co. KGaA
    • Kamiya Biomedical Company（Nitto Boseki Co. Ltd.）
    • Lee Biosolutions Inc.（Oy Medix Biochemica Ab）
    • Merck & Co. Inc.
    • Prospec-Tany Technogene Ltd.
    • Scripps Laboratories Inc.
    • Sun Pharmaceutical Industries Limited
Product Code: SR112026A7059

The global human chorionic gonadotropin (HCG) market size reached USD 1,103.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,905.9 Million by 2034, exhibiting a growth rate (CAGR) of 6.07% during 2026-2034. The rising incidences of infertility in women, increasing prevalence of hypogonadism-related disorders, and production of HCG using recombinant technology represent some of the key factors driving the market.

Human chorionic gonadotropin (HCG) is a chemical produced by syncytiotrophoblastic cells of the placenta during pregnancy. It is found in blood, urine, liver, colon, and pituitary glands. HCG stimulates the corpus luteum to produce progesterone to maintain the pregnancy. It is extracted and purified from the urine of pregnant women for clinical applications using various techniques, such as ion exchange chromatography, dye-affinity chromatography, nanofiltration, and reverse-phase high-performance liquid chromatography (HPLC). HCG is widely used to treat infertility, increase the chances of pregnancy, help in the production of testosterone and sperm, and treat cryptorchidism in male children. It also aids in diagnosing and monitoring pregnancy-related disorders, prenatal screening, and gynecological cancers.

HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET TRENDS:

The rising incidences of infertility among females due to uterine disorders, blocked fallopian tube, polycystic ovarian syndrome (PCOS), and endocrine system disorders are among the key factors driving the market growth. HCG is widely used in various assisted reproductive technologies, such as in-vitro fertilization (IVF) and intrauterine insemination (IUI), to treat female infertility, as it aids in inducing ovulation, promotes the formation of the embryo, facilitates correct timing of oocyte retrieval, increases endometrial thickness, and improve endometrial receptivity. In addition to this, the widespread product utilization in combination with other fertility drugs to increase the chances of pregnancy in women is acting as another growth-inducing factor. Furthermore, the increasing application of HCG to improve testosterone levels, enhance fertility, and promote sexual function due to the increasing prevalence of hypogonadism-related disorders in males suffering from obesity and type 2 diabetes is favoring the market growth. Additionally, the production of HCG using recombinant technology that provides identical properties, enhanced efficacy, and improved safety compared to naturally sourced HCG and enhances patient tolerance is positively influencing the market growth. Other factors, including the rapid development of healthcare infrastructure, increasing availability of treatment and services regarding infertility, rising geriatric population, extensive research and development (R&D) activities for the launch of novel purification and extraction technologies, and the implementation of various government initiatives to improve the sexual health of people, are anticipated to drive the market growth further.

KEY MARKET SEGMENTATION:

Technology Insights:

  • Natural Source Extraction
  • Recombinant Technology

The report has also provided a detailed breakup and analysis of the human chorionic gonadotropin (HCG) market based on the technology. This includes natural source extraction and recombinant technology. According to the report, natural source extraction represented the largest segment.

Therapeutic Area Insights:

  • Female Infertility Treatment
  • Male Hypogonadism
  • Oligospermic Treatment
  • Others

End User Insights:

  • Fertility Clinics
  • Research Institutions
  • Others

Regional Insights:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for human chorionic gonadotropin (HCG). Some of the factors driving the North America human chorionic gonadotropin (HCG) market include rising incidences of infertility among women, growing consumer awareness regarding the available treatment for infertility and gynecological concerns, and rising expenditure capacities of consumers.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global human chorionic gonadotropin (HCG) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Biocare Medical LLC, Ferring Pharmaceuticals, Fresenius SE & Co. KGaA, Kamiya Biomedical Company (Nitto Boseki Co. Ltd.), Lee Biosolutions Inc. (Oy Medix Biochemica Ab), Merck & Co. Inc., Prospec-Tany Technogene Ltd., Scripps Laboratories Inc., Sun Pharmaceutical Industries Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global human chorionic gonadotropin (HCG) market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global human chorionic gonadotropin (HCG) market?
  • What are the key regional markets?
  • Which countries represent the most attractive human chorionic gonadotropin (HCG) markets?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the therapeutic area?
  • What is the breakup of the market based on the end user?
  • What is the competitive structure of the global human chorionic gonadotropin (HCG) market?
  • Who are the key players/companies in the global human chorionic gonadotropin (HCG) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Human Chorionic Gonadotropin (HCG) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Natural Source Extraction
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Recombinant Technology
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Therapeutic Area

  • 7.1 Female Infertility Treatment
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Male Hypogonadism
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Oligospermic Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Fertility Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Institutions
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Biocare Medical LLC
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Ferring Pharmaceuticals
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Fresenius SE & Co. KGaA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Kamiya Biomedical Company (Nitto Boseki Co. Ltd.)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Lee Biosolutions Inc. (Oy Medix Biochemica Ab)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Prospec-Tany Technogene Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Scripps Laboratories Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Sun Pharmaceutical Industries Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Human Chorionic Gonadotropin Market: Major Drivers and Challenges
  • Figure 2: Global: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Human Chorionic Gonadotropin Market: Breakup by Technology (in %), 2025
  • Figure 5: Global: Human Chorionic Gonadotropin Market: Breakup by Therapeutic Area (in %), 2025
  • Figure 6: Global: Human Chorionic Gonadotropin Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Human Chorionic Gonadotropin Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Human Chorionic Gonadotropin (Natural Source Extraction) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Human Chorionic Gonadotropin (Natural Source Extraction) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Human Chorionic Gonadotropin (Recombinant Technology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Human Chorionic Gonadotropin (Recombinant Technology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Human Chorionic Gonadotropin (Female Infertility Treatment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Human Chorionic Gonadotropin (Female Infertility Treatment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Human Chorionic Gonadotropin (Male Hypogonadism) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Human Chorionic Gonadotropin (Male Hypogonadism) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Human Chorionic Gonadotropin (Oligospermic Treatment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Human Chorionic Gonadotropin (Oligospermic Treatment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Human Chorionic Gonadotropin (Other Therapeutic Areas) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Human Chorionic Gonadotropin (Other Therapeutic Areas) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Human Chorionic Gonadotropin (Fertility Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Human Chorionic Gonadotropin (Fertility Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Human Chorionic Gonadotropin (Research Institutions) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Human Chorionic Gonadotropin (Research Institutions) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Human Chorionic Gonadotropin (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Human Chorionic Gonadotropin (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: North America: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: North America: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: United States: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: United States: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Canada: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Canada: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Asia-Pacific: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Asia-Pacific: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: China: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: China: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Japan: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Japan: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: India: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: India: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: South Korea: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: South Korea: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Australia: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Australia: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Indonesia: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Indonesia: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Others: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Others: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Europe: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Europe: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Germany: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Germany: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: France: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: France: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: United Kingdom: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: United Kingdom: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Italy: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Italy: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Spain: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Spain: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Russia: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Russia: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Others: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Others: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Latin America: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Latin America: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Brazil: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Brazil: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Mexico: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Mexico: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Others: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Others: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Middle East and Africa: Human Chorionic Gonadotropin Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Middle East and Africa: Human Chorionic Gonadotropin Market: Breakup by Country (in %), 2025
  • Figure 74: Middle East and Africa: Human Chorionic Gonadotropin Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Global: Human Chorionic Gonadotropin Industry: Drivers, Restraints, and Opportunities
  • Figure 76: Global: Human Chorionic Gonadotropin Industry: Value Chain Analysis
  • Figure 77: Global: Human Chorionic Gonadotropin Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Human Chorionic Gonadotropin Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 3: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by Therapeutic Area (in Million USD), 2026-2034
  • Table 4: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Human Chorionic Gonadotropin Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Human Chorionic Gonadotropin Market: Competitive Structure
  • Table 7: Global: Human Chorionic Gonadotropin Market: Key Players